| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000039769 |
| Receipt No. | R000045354 |
| Scientific Title | Effect of chocolate containing D-allulose on postprandial lipidemia |
| Date of disclosure of the study information | 2020/03/12 |
| Last modified on | 2020/03/11 (Ver. 2) |
| Basic information | ||
| Public title | Effect of chocolate containing D-allulose on postprandial lipidemia | |
| Acronym | Effect of chocolate containing D-allulose on postprandial lipidemia | |
| Scientific Title | Effect of chocolate containing D-allulose on postprandial lipidemia | |
| Scientific Title:Acronym | Effect of chocolate containing D-allulose on postprandial lipidemia | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluate the effest of chocolate containing D-allulose on postprandial lipidemia |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Triglyceride until 6 hours after consumption |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of chocolate containing sucrose | |
| Interventions/Control_2 | Intake of chocolate containing sucrose and 1.8g D-allulose | |
| Interventions/Control_3 | Intake of chocolate containing sucrose and 3.6g D-allulose | |
| Interventions/Control_4 | Intake of chocolate containing sucrose and 12.5g D-allulose | |
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1)Healthy adults
2)Subjects with regular ovarian cycles 3)Subjects with apolipoprotein E phenotype 3/3 |
|||
| Key exclusion criteria | 1)Subjects with apparent acute or chronic illnesses
2)Subjects who have any medications and dietary supplements. |
|||
| Target sample size | 8 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Sugiyama Jogakuen University | ||||||
| Division name | School & Graduate School of Life Studies | ||||||
| Zip code | 464-8662 | ||||||
| Address | 17-3, Hoshigaoka-motomachi, Chikusa-ku, Nagoya, Japan | ||||||
| TEL | 0527814603 | ||||||
| naito@sugiyama-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Matsutani Chemical Industry Co., Ltd. | ||||||
| Division name | Reseach and Development | ||||||
| Zip code | 664-8508 | ||||||
| Address | 5-3 Kita-Itami, Itami, Hyogo, Japan | ||||||
| TEL | 0727712052 | ||||||
| Homepage URL | |||||||
| misuzu-tanaka@matsutani.co.jp | |||||||
| Sponsor | |
| Institute | Sugiyama Jogakuen University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Matsutani Chemical Industry Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | the Institutional Review Board of Sugiyama Jogakuen University School of Life Studies |
| Address | 17-3, Hoshigaoka-motomachi, Chikusa-ku, Nagoya, Japan |
| Tel | 0527814603 |
| naito@sugiyama-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | ||
| URL related to results and publications | ||
| Number of participants that the trial has enrolled | 8 | |
| Results | ||
| Results date posted | ||
| Results Delayed |
|
|
| Results Delay Reason | To submit a paper during preparation | |
| Date of the first journal publication of results | ||
| Baseline Characteristics | ||
| Participant flow | ||
| Adverse events | ||
| Outcome measures | ||
| Plan to share IPD | ||
| IPD sharing Plan description | ||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045354 |